Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.534
-0.008 (-1.46%)
Oct 3, 2024, 4:00 PM EDT - Market closed

Silexion Therapeutics Statistics

Total Valuation

SLXN has a market cap or net worth of $4.44 million. The enterprise value is $20.30 million.

Market Cap 4.44M
Enterprise Value 20.30M

Important Dates

The next estimated earnings date is Thursday, November 21, 2024, before market open.

Earnings Date Nov 21, 2024
Ex-Dividend Date n/a

Share Statistics

SLXN has 8.32 million shares outstanding.

Shares Outstanding 8.32M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.12
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.85

Current Ratio 3.85
Quick Ratio 3.64
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -452.67

Financial Efficiency

Return on equity (ROE) is -116.66% and return on invested capital (ROIC) is -73.07%.

Return on Equity (ROE) -116.66%
Return on Assets (ROA) -62.13%
Return on Capital (ROIC) -73.07%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) -0.12
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 30.39
Average Volume (20 Days) 6,399,434

Short Selling Information

The latest short interest is 3,850, so 0.05% of the outstanding shares have been sold short.

Short Interest 3,850
Short Previous Month 4,315
Short % of Shares Out 0.05%
Short % of Float n/a
Short Ratio (days to cover) 0.98

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.36M
Pretax Income n/a
Net Income -1.36M
EBITDA -1.36M
EBIT -1.36M
Earnings Per Share (EPS) -$9.09
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 788,000
Total Debt n/a
Net Cash 788,000
Net Cash Per Share $0.09
Equity (Book Value) 696,000
Book Value Per Share 4.67
Working Capital 687,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$794,000 and capital expenditures -$5,000, giving a free cash flow of -$799,000.

Operating Cash Flow -794,000
Capital Expenditures -5,000
Free Cash Flow -799,000
FCF Per Share -$0.10
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SLXN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -30.07%
FCF Yield -17.73%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1